Clinical trial

N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis

NCT01354132

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-05-01

PhasePHASE2

Study timeline

Study start (unknown)2011-05-01Date precision: month

Registry last updated2017-07-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophrenic Psychosesunresolved

Interventions

n-acetylcysteineDRUG

PlaceboDRUG

Sponsors & collaborators

Beth Israel Deaconess Medical Centerlead sponsor

Center de Neurosciences Psychiatrique, Lausanne, Switzerlandcollaborator

Mapped research locations

BostonMassachusetts, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01354132 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.